We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

AndroGel Buyer Seeks 2nd Shot At Pay-For-Delay Suit

Law360 (March 8, 2010, 12:25 PM EST) -- An indirect purchaser of Solvay Pharmaceuticals Inc.'s testosterone supplement AndroGel has asked for leave to amend a recently dismissed putative class action accusing the drugmaker of keeping generics rivals out of the market by paying them through patent settlements.

The lead indirect purchaser plaintiff — the Fraternal Order of Police, Fort Lauderdale Lodge 31, Insurance Trust Fund — filed a motion Friday in the U.S. District Court for the Northern District of Georgia, arguing it should be allowed to amend its complaint because it was never given a chance to do so before the dismissal, even though a direct purchaser plaintiff...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!